Abstract
Over the past decade, marrow transplantation has progressed from a very experimental approach applied only to a handful of endstage leukemic patients to an important therapeutic option appropriate for many patients. In this paper we will describe the role marrow transplantation plays in the treatment of acute nonlymphoblastic leukemia (ANL) in adults. In order to define this role, the outcome of marrow transplantation obviously must be compared to that of more conventional chemotherapy for specific patient groups at given stages of their disease. Such comparisons are best made in prospective studies but only a few such studies have been performed and completed. For many patient groups only retrospective comparisons are possible. Retrospective analyses are inherently flawed and serve only as estimates. For some patient groups not even retrospective comparisons are possible because adequate data are not available.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Clift RA, Hansen JA, Thomas ED, Buckner CD, Sanders JE, Mickelson EM, Storb R, Johnson FL, Singer JW, Goodell BW: Marrow transplantation from donors other than HLA-identical siblings. Transplantation 28: 235–242, 1979.
Thomas ED, Storb R, Clift RA, Fefer A, Johnson FL, Neiman PE, Lerner KG, Glucksberg H, Buckner CD: Bone-marrow transplantation. N. Engl. J. Med. 292:832–843, 895–902, 1975.
Buckner CD, Clift RA, Thomas ED, Sanders JE, Stewart PS, Storb R, Sullivan KM, Hackman R: Allogeneic marrow transplantation for acute non-lymphoblastic leukemia in relapse using fractionated total body irradiation. Leuk. Res. 6: 389–394, 1982.
Badger C, Buckner CD, Thomas ED, Clift RA, Sanders JE, Stewart PS, Storb R, Sullivan KM, Shulman H, Flournoy N: Allogeneic marrow transplantation for acute leukemia in relapse. Leuk. Res. 6: 383–387, 1982.
Santos GW, Tutschka PJ, Brookmeyer R, Saral R, Beschorner WE, Bias WB, Braine HG, Burns WH, Elfenbein GJ, Kaizer H, Mellits D, Sensenbrenner LL, Stuart RK, Yeager AM: Marrow transplantation for acute nonlymphocytic leukemia after treatment with busulfan and cyclophosphamide. N. Engl. J. Med. 309: 1347–1358, 1983.
Giucksberg H, Cheever MA, Farewell VT, Fefer A, Sale GE, Thomas ED: High-dose combination chemotherapy for acute nonlymphoblastic leukemia in adults. Cancer 48: 1073 1081, 1981.
Preisler H, Anderson K, Rai K, Cuttner J, Yates J: Com- parison of survival of patients with acute nonlymphocytic leukemia receiving maintenance chemotherapy or marrow transplantation in 1st remission. ASCO (abstract C691 ), 177, 1983.
Thomas ED, Buckner CD, Banaji M, Clift RA, Fefer A, Flournoy N, Goodell BW, Hickman RO, Lerner KG, Neiman ‘PE, Sale GE, Sanders JE, Singer J, Stevéns M, Storb, R, Weiden PL: One hundred patients with acute leukemia treated by chemotherapy, total body irradiation, and allogeneic marro transplantation. Blood 49: 511–533, 1977.
Thomas ED: Marrow transplantation for malignant diseases (Karnofsky Memorial Lecture). J. Clin. Oncol. 1: 517–531, 1983.
Buckner CD, Clift RA, Thomas ED, Sanders JE, Hackman R, Stewart PS, Storb R, Sullivan KM: Allogeneic marrow trans plantation for patients with acute non-lymphoblastic leukemia in second remission. Leuk. Res. 6: 395–399, 1982.
Appelbaum FR, Clift RA, Buckner CD, Stewart P, Storb R, Sullivan KM, Thomas ED: Allogeneic marrow transplantation for acute nonlymphoblastic leukemia after first relapse. Blood 61: 949–953, 1983.
Peterson BA, Bloomfield CD: Re-induction of complete remissions in adults with acute non-lymphocytic leukemia. Leuk. Res. 5: 81–88, 1981.
Foon KA, Gale RP: Controversies in the therapy of acute myelogenous leukemia. Am. J. Med. 72: 963–979, 1982.
Gale RP: Advances in the treatment of acute myelogenous leukemia. N. Engl. J. Med. 300: 1189–1199, 1979.
Lister TA, Rohatiner AZS: The treatment of acute myelogenous leukemia in adults. Semin. Hematol. 19: 172–192, 1982.
Weinstein HJ, Mayer RJ, Rosenthal DS, Coral FS, Camitta BM Gelber RD: Chemotherapy for acute myelogenous leukemia in children and adults: VAPA update. Blood 62: 315–319, 1983.
Yates J, Glidewell O, Wiernik P, Cooper MR, Steinberg D, Dosik H, Levy R, Hoagland C, Henry P, Gottlieb A, Cornell C, Berenberg J, Hutchison JL, Raich P, Nissen N, Ellison RR, Frelick R, James GW, Falkson G, Silver RT, Haurani F, Green M, Henderson E, Leone L, Holland JF: Cytosine arabinoside with daunorubicin or adriamycin for therapy of acute myelocytic leukemia: A CALGB study. Blood 60: 454462, 1982.
Keating MJ, Smith TL, McCredie KB, Bodey GP, Hersh EM, Gutterman JU, Gehan E, Freireich EJ: A four-year experience with anthracycline, cytosine arabinoside, vincristin and prednisone combination chemotherapy in 325 adults with acute leukemia. Cancer 47: 2779–2788, 1981.
Thomas ED, Buckner CD, Clift RA, Fefer A, Johnson FL, Neiman PE, Sale GE, Sanders JE, Singer JW, Shulman H, Storb R, Weiden PL: Marrow transplantation for acute non-lympho-blastic leukemia in first remission. N. Engl. J. Med. 301: 597–599, 1979.
Thomas ED: Marrow transplant for acute nonlymphoblastic leukemia in first remission: A follow-up. (Letter.) N. Engl. J. Med. 308: 1539–1540, 1983.
Powles RL, Morgenstern G, Clink HM, Hedley D, Bandini G, Lumley H, Watson JG, Lawson D, Spence D, Barrett A, Jameson B, Lawler S, Kay HEM, McElwain TJ: The place of bone-marrow transplantation in acute myelogenous leukemia. Lancet i: 1047–1050, 1980.
Kersey JH, Ramsay NKC, Kim T, McGlave P, Krivit W, Levitt S, Filipovich A, Woods W, O’Leary M, Coccia P, Nesbit ME: Allogeneic bone marrow transplantation in acute nonlymphocytic leukemia: A pilot study. Blood 60: 400–403, 1982.
Forman SJ, Spruce WE, Farbstein MJ, Wolf JL, Scott EP, Nademanee AP, Fahey JL, Hecht T, Zaia JA, Krance RA, Findley DO, Blume KG: Bone marrow ablation followed by allo eneic marrow grafting during first complete remission of acute nonlymphocytic leukemia. Blood 61: 439–442, 1983.
Preisler HD: An integrated approach to the study and treatment of acute myelocytic leukemia. In: Bloomfield CD, ed. Adult Leukemias 1. The Hague: Martinus Nijhoff, 1982, pp. 155–197.
Stryckmans P, Debusscher L, Ronge-Collard E, Socquet M, Zittoun R: The labelling index of marrow myeloblasts: A predictive test for relapse of acute non-lymphoblastic leukemia. Leuk. Res. 4: 79–87, 1980.
McCulloch EA, Curtis JE, Messner HA, Senn JS, Germanson TP: The contribution of blast cell properties to outcome variation in acute myeloblastic leukemia (AML). Blood 59: 601–608, 1982.
Hittelman WN, Broussard LC, Dosik G, McCredie KB: Predicting relapse of human leukemia by means of premature chromosome condensation. N. Engl. J. Med. 303: 479–484, 1980.
Baker MA, Falk JA, Carter WH, Taub RN and the Toronto Leukemia Study Group: Early diagnosis of relapse in acute myeloblastic leukemia: Serologic detection of leukemia-associated antigens in human marrow. N. Engl. J. Med. 301: 1353–1357, 1979.
Carpentier NA, Fiere DM, Schuh D, Lange GT, Lambert P-H: Circulating immune complexes and the prognosis of acute myeloid leukemia. N. Engl. J. Med. 307: 1174–1180, 1982.
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1985 Martinus Nijhoff Publishing, Boston
About this chapter
Cite this chapter
Appelbaum, F.R., Thomas, E.D. (1985). Allogeneic Marrow Transplantation for Acute Nonlymphoblastic Leukemia in Adults. In: Baker, L., Valeriote, F., Ratanatharathorn, V. (eds) Biology and Therapy of Acute Leukemia. Developments in Oncology, vol 33. Springer, Boston, MA. https://doi.org/10.1007/978-1-4613-2609-0_12
Download citation
DOI: https://doi.org/10.1007/978-1-4613-2609-0_12
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4612-9633-1
Online ISBN: 978-1-4613-2609-0
eBook Packages: Springer Book Archive